The feasibility of utilizing plasma MiRNA107 and BACE1 messenger RNA gene expression for clinical diagnosis of amnestic mild cognitive impairment.

@article{Wang2015TheFO,
  title={The feasibility of utilizing plasma MiRNA107 and BACE1 messenger RNA gene expression for clinical diagnosis of amnestic mild cognitive impairment.},
  author={Tao Wang and Kewei Chen and Huafang Li and Shuhui Dong and Ning Su and Yuanyuan Liu and Yan Shun Cheng and Jing Dai and Cece Yang and Shifu Xiao},
  journal={The Journal of clinical psychiatry},
  year={2015},
  volume={76 2},
  pages={135-41}
}
OBJECTIVE To investigate the relationship between microRNA107 (miRNA107) and BACE1 messenger RNA (mRNA) gene expressions in plasma and their diagnostic capability to distinguish subjects with amnestic mild cognitive impairment from healthy controls. METHOD We recruited 97 patients with Alzheimer's disease according to diagnostic criteria of DSM-IV and National Institute of Neurologic and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association, 116 subjects… CONTINUE READING
7 Citations
38 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 38 references

Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease

  • B. De Strooper
  • 2015
3 Excerpts

Similar Papers

Loading similar papers…